• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于从软珊瑚中提取的甾体对丙型肝炎病毒NS3/4A蛋白酶的作用。

On the steroids extracted from soft corals against the NS3/4A protease of hepatitis C virus.

作者信息

Nguyen Duy Phuong, Nguyen Ha Xuan, Van Nguyen Hue, Dang Linh Mai, Nguyen Minh Tho, Minh Nguyen Hue Thi

机构信息

Faculty of Chemistry and Center for Computational Science, Hanoi National University of Education, Hanoi, Viet Nam.

Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology, Hanoi, Viet Nam.

出版信息

J Mol Graph Model. 2025 May;136:108936. doi: 10.1016/j.jmgm.2024.108936. Epub 2024 Dec 27.

DOI:10.1016/j.jmgm.2024.108936
PMID:39793475
Abstract

The Hepatitis C virus (HCV) causes a variety of liver diseases, making it a global health issue that affects millions of people in the world. The NS3/4A protease has been considered a common target for anti-HCV treatments using direct-acting antiviral agents and their derivatives. Of the natural products that have been proposed for novel therapeutic product alternatives, the soft coral compounds are found to contain steroids with various bioactive properties for effective HCV treatments. They are screened to search for HCV inhibitors using computational approaches to screen for potential HCV inhibitors from the extracts of soft corals. Among 188 steroids considered, the five top compounds are selected for evaluation of binding affinities and stabilities using molecular docking and dynamics simulations, as well as with absorption, distribution, metabolism, excretion, and toxicity to assess the drug's performance.

摘要

丙型肝炎病毒(HCV)会引发多种肝脏疾病,使其成为一个影响全球数百万人的全球性健康问题。NS3/4A蛋白酶一直被视为使用直接抗病毒药物及其衍生物进行抗HCV治疗的常见靶点。在被提议作为新型治疗产品替代品的天然产物中,发现软珊瑚化合物含有具有多种生物活性特性的类固醇,可有效治疗HCV。通过计算方法从软珊瑚提取物中筛选潜在的HCV抑制剂,对它们进行筛选以寻找HCV抑制剂。在188种被考虑的类固醇中,选择了五种顶级化合物,使用分子对接和动力学模拟评估其结合亲和力和稳定性,并评估其吸收、分布、代谢、排泄和毒性,以评估药物性能。

相似文献

1
On the steroids extracted from soft corals against the NS3/4A protease of hepatitis C virus.关于从软珊瑚中提取的甾体对丙型肝炎病毒NS3/4A蛋白酶的作用。
J Mol Graph Model. 2025 May;136:108936. doi: 10.1016/j.jmgm.2024.108936. Epub 2024 Dec 27.
2
Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease.基于药效团的共价对接鉴定出一种潜在的针对丙型肝炎病毒 NS3/4A 丝氨酸蛋白酶耐药基因型 3 变异体的共价抑制剂。
Viruses. 2024 Aug 3;16(8):1250. doi: 10.3390/v16081250.
3
Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3/4A protease: Structural and molecular simulation-based insights.解析 HCV NS3/4A 蛋白酶中 Sofosbuvir 耐药的机制:结构和分子模拟的见解。
Int J Biol Macromol. 2024 May;267(Pt 2):131629. doi: 10.1016/j.ijbiomac.2024.131629. Epub 2024 Apr 16.
4
Structure-based virtual screening of natural compounds against wild and mutant (R1155K, A1156T and D1168A) NS3-4A protease of Hepatitis C virus.基于结构的天然化合物针对丙型肝炎病毒野生型和突变型(R1155K、A1156T和D1168A)NS3-4A蛋白酶的虚拟筛选
J Biomol Struct Dyn. 2024 Oct;42(16):8505-8522. doi: 10.1080/07391102.2023.2246583. Epub 2023 Aug 30.
5
Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.通过组合蛋白-配体相互作用指纹、3D 药效团、对接和动态模拟鉴定 HCV NS3 基因型 4a 的潜在抑制剂。
J Biomol Struct Dyn. 2018 May;36(7):1713-1727. doi: 10.1080/07391102.2017.1332689. Epub 2017 Jun 7.
6
Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations.用二肽抑制剂阐明寨卡病毒NS2B-NS3蛋白酶的抑制机制:来自分子对接和分子动力学模拟的见解
PLoS One. 2024 Aug 8;19(8):e0307902. doi: 10.1371/journal.pone.0307902. eCollection 2024.
7
Repurposing of antiparasitic drugs against the NS2B-NS3 protease of the Zika virus.抗寄生虫药物对 Zika 病毒 NS2B-NS3 蛋白酶的重新利用。
J Biomol Struct Dyn. 2024;42(19):10101-10113. doi: 10.1080/07391102.2023.2255648. Epub 2023 Sep 25.
8
Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry.大环丙型肝炎病毒NS3/4A蛋白酶抑制剂:药物化学概述
Curr Med Chem. 2016;23(29):3404-3447. doi: 10.2174/0929867323666160510122525.
9
Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs.基于结构的虚拟筛选 FDA 批准药物鉴定寨卡病毒 NS2B-NS3 蛋白酶和 NS5 聚合酶抑制剂。
J Biomol Struct Dyn. 2024 Sep;42(15):8073-8088. doi: 10.1080/07391102.2023.2242963. Epub 2023 Aug 1.
10
Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.鉴定新型小分子抑制剂抗丙型肝炎病毒 4a 基因型 NS3/4A 蛋白酶。
Curr Pharm Des. 2018;24(37):4484-4491. doi: 10.2174/1381612825666181203153835.